| 11. |
Glimepiride: improved glycaemic control and cardiovascular benefits |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 13-15
M Buckley,
RM Poole,
Preview
|
|
摘要:
The second-generation sulphonylurea, glimepiride, provides glycaemic control for patients with type 2 diabetes mellitus and exerts beneficial ancillary effects on other cardiovascular risk factors, according to studies presented at the 18th Congress of the International Diabetes Federation (IDF) [Paris, France; August 2003]. These studies demonstrated that glimepiride, as monotherapy or in combination with metformin or rosiglitazone, improved glycaemic control without causing significant increases in bodyweight or high incidences of hypoglycaemic events. Furthermore, treatment with glimepiride produced significant improvements in cardiovascular risk factors, including BP, lipid metabolism and myocardial function, suggesting unique benefits of this agent in type 2 diabetes.
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 12. |
"Combination therapy with caspofungin and liposomal amphotericin B could be a useful treatment option for very young patients who have refractory aspergillosis", |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 15-15
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 13. |
SDD improves survival in ICU patients |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 16-16
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 14. |
LMWHs versus NSAIDs for superficial vein thrombosis |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 17-17
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 15. |
The anti-CD52 antibody alemtuzumab is promising for the treatment of advanced or refractory lymphoproliferative disorders, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 18-18
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 16. |
Antiretrovirals affect host-P. falciparuminteractions |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 19-19
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 17. |
Lipid-lowering drugs not associated with depression |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 20-20
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 18. |
EU regulatory news |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 21-21
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 19. |
Thyrotropin alfa ['Thyrogen'; Genzyme Corporation] has received an extended European label. |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 22-22
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 20. |
Product Introductions |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1407,
2003,
Page 23-23
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
首页
